• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Request Free Sample ×
    Human Growth Hormone Market Research Report - Global Forecast till 2032 Infographic

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    Human Growth Hormone Market

    ID: MRFR/HC/5032-CR
    175 Pages
    Kinjoll Dey
    February 2021

    Human Growth Hormone Market Research Report Information by Brand (Norditropin, Genotropin, Humatrope, Saizen, Omnitrope, Skytrofa, and Others), by Route of Administration (Subcutaneous, Intramuscular, and Intravenous), by Application (Pediatric Growth Hormone Deficiency, Adult, Growth Hormone Deficiency, Idiopathic Growth Hormone Deficiency, Small for Gestational Age, Turner Syndrome, Prader-Willi Syndrome, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacy, and Specialty Pharmacy), and By Region (N...

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Human Growth Hormone Market Research Report - Global Forecast till 2032 Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Compare License
    Table of Contents

    Human Growth Hormone Market Summary

    The Global Human Growth Hormone Market is projected to grow significantly from 6.9 USD Billion in 2024 to 18.6 USD Billion by 2035.

    Key Market Trends & Highlights

    Human Growth Hormone Key Trends and Highlights

    • The market is expected to experience a compound annual growth rate (CAGR) of 9.44% from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 18.6 USD Billion, indicating robust growth potential.
    • In 2024, the market is valued at 6.9 USD Billion, reflecting the current demand for human growth hormone therapies.
    • Growing adoption of advanced therapies due to increasing awareness of growth disorders is a major market driver.

    Market Size & Forecast

    2024 Market Size 6.9 (USD Billion)
    2035 Market Size 18.6 (USD Billion)
    CAGR (2025-2035) 9.44%

    Major Players

    Novo Nordisk A/S (Denmark), Pfizer Inc. (US), Ascendis Pharma A/S (Denmark), EMD Serono (US), Ferring B.V. (Switzerland), Zhongshan Sinobioway Hygene Biomedicine Co., Ltd (China), Sandoz International GmbH (Germany), AnkeBio Co., Ltd (China), Ipsen Pharma (France), Genentech (US)

    Human Growth Hormone Market Trends

    Rising Incidence of Growth Hormone Deficiency Boosts Market Growth

    Cushing's syndrome,turner syndrome, down syndrome, Noonan syndrome, Russell-silver syndrome, Prader Willi syndrome, and others are the most common growth hormone disorders across the globe. For instance, in March 2019, according to the National Organization for Rare Disorders, in the US, turner syndrome affects approximately 1 female in 2,000 to 2,500 live female births and estimated that more than 70,000 women and girls have turner syndrome.

    Moreover, growth hormone deficiency is caused by structural pituitary disease or cranial irradiation and occurs in the context of additional features of hypopituitarism.

    Early Diagnosis and Awareness Initiatives

    Moreover, early diagnosis of endocrine disorders such as Addison’s disease, Cushing’s disease, graves' disease, Hashimoto thyroiditis, hyperthyroidism/hypothyroidism, prolactinoma, and others can substantially improve the chances of successful treatment and prevent severe complications.

    The government and various international organizations have launched a number of initiatives to raise awareness about early diagnosis. For instance, The International Coalition of Organizations Supporting Endocrine Patients (ICOSEP), a US-based nonprofit charitable organization, celebrates International Children’s Growth Awareness Day every year to spread awareness about the early diagnosis and treatment of growth hormone deficiency.

    The Global Human Growth Hormone Market appears to be experiencing a notable expansion, driven by increasing awareness of growth hormone deficiencies and advancements in biotechnology.

    U.S. Food and Drug Administration (FDA)

    Human Growth Hormone Market Drivers

    Market Growth Projections

    The Global Human Growth Hormone Market Industry is projected to experience substantial growth over the next decade. With a market value of 6.9 USD Billion in 2024, it is anticipated to expand to 18.6 USD Billion by 2035. This growth trajectory is indicative of a compound annual growth rate (CAGR) of 9.44% from 2025 to 2035. Such projections highlight the increasing demand for human growth hormone therapies across various demographics, including children with growth disorders and adults seeking anti-aging treatments. The market's expansion reflects broader trends in healthcare and biotechnology, emphasizing the importance of continued research and development in this field.

    Advancements in Biotechnology

    Technological advancements in biotechnology are significantly influencing the Global Human Growth Hormone Market Industry. Innovations in recombinant DNA technology have enabled the production of synthetic growth hormones that are safer and more effective than their predecessors. These advancements not only enhance the efficacy of treatments but also reduce the risk of side effects, making them more appealing to healthcare providers and patients alike. As a result, the market is expected to grow substantially, with projections indicating a rise to 18.6 USD Billion by 2035. The continuous evolution of biopharmaceuticals is likely to drive further investment and research in this sector.

    Growing Awareness and Education

    The rising awareness and education surrounding the benefits of human growth hormone therapy are significantly impacting the Global Human Growth Hormone Market Industry. Healthcare professionals and patients are becoming more informed about the potential advantages of growth hormone treatments, leading to increased demand. Educational initiatives aimed at both practitioners and the public are fostering a better understanding of growth hormone deficiencies and their implications. This heightened awareness is expected to drive market growth, as more individuals seek out therapies that can improve their health outcomes and quality of life.

    Regulatory Approvals and Guidelines

    The establishment of favorable regulatory frameworks and guidelines for the use of human growth hormone is a crucial driver for the Global Human Growth Hormone Market Industry. Regulatory bodies are increasingly recognizing the therapeutic benefits of growth hormone therapy, leading to streamlined approval processes for new treatments. This trend encourages pharmaceutical companies to invest in research and development, ultimately resulting in a wider array of products available in the market. As regulations evolve to support safe and effective use, the market is likely to experience accelerated growth, further solidifying its position in the healthcare landscape.

    Increased Focus on Anti-Aging Treatments

    The growing interest in anti-aging treatments among the aging population is propelling the Global Human Growth Hormone Market Industry. Human growth hormone is often marketed for its potential to improve vitality, muscle mass, and overall well-being in older adults. As the demographic of individuals aged 50 and above expands, there is a corresponding increase in demand for therapies that promote longevity and enhance quality of life. This trend is anticipated to contribute to a compound annual growth rate (CAGR) of 9.44% from 2025 to 2035, reflecting the market's potential to cater to this demographic's needs.

    Rising Prevalence of Growth Hormone Deficiency

    The increasing incidence of growth hormone deficiency among children and adults is a primary driver of the Global Human Growth Hormone Market Industry. This condition, which can lead to stunted growth and other health complications, necessitates effective treatment options. As awareness of growth hormone deficiency grows, more individuals seek medical intervention, thereby expanding the market. In 2024, the market is projected to reach 6.9 USD Billion, reflecting the urgent need for therapies that address this deficiency. The rising prevalence of related disorders, such as Turner syndrome and Prader-Willi syndrome, further underscores the demand for human growth hormone therapies.

    Market Segment Insights

    Human Growth Hormone Brand Insights

    The Human Growth Hormone market segmentation, based on brand, includes Norditropin, Genotropin, Humatrope, Saizen, Omnitrope, Skytrofa, and others. The Norditropin segment held the largest market in 2021 reaching a market value of USD 3.46 billion by 2032. The Skytrofa segment is expected to register the highest CAGR of 11.37% from 2024 to 2032.

    This is owing to the growing occurrences of growth hormone deficiency diseases, and technological advances, such as recombinant DNA technology, which is anticipated to fuel the growth of the segment. Moreover, Novo Nordisk’s (Denmark) Norditropin HGH injections are conveniently preloaded pen systems that are premixed and prefilled.

    The market share for this brand is attributed to the brand value, product quality, convenience, and simplicity of administration. Furthermore, Norditropin is convenient to store while traveling as it does not require refrigeration after activation, which increases its preference among patients.

    August 2021: Ascendis Pharma A/S (Denmark) has received the US Food and Drug Administration (FDA) approval for SKYTROFA (lonapegsomatropin-tcgd) for treating pediatric patients aged one year and older.

    Human Growth Hormone Route of Administration Insights

    The Human Growth Hormone market segmentation, based on route of administration, includes subcutaneous, intramuscular, and intravenous. The subcutaneous segment held the largest market in 2021, and the intramuscular segment is expected to register the highest CAGR from 2024 to 2032.

    The growth of the subcutaneous segment is increasing as it leads to a significant rise in growth rates in patients and a low incidence of antibody development. The majority of GHD drugs are administered through the subcutaneous route of administration. For instance, brands such as Norditropin, Genotropin, Humatrope, Omnitrope, Nutropin, and Saizen are administered subcutaneously.

    This route of administration injection is reported to be less painful and easier to self-administer. It is also preferred in children and adults, eventually by means of easy-to-use pen-type delivery devices. Moreover, the subcutaneous route is highly preferred for chronic growth hormone therapy.

    Human Growth Hormone Application Insights

    The growth hormone market data has been segmented by application into pediatric growth hormone deficiency, adult growth hormone deficiency, idiopathic growth hormone deficiency, small for gestational age, turner syndrome, Prader Willi syndrome, and others. The pediatric growth hormone deficiency segment dominated the market in 2021 and small for gestational age is projected to be the faster-growing segment during the forecast period, 2022-2032.

    Growth hormone deficiency is an endocrine disorder characterized by the low secretion of growth hormones. The market share for the growth hormone deficiency segment is due to the growing prevalence of GHD, increasing penetration of drugs by prominent market players, and increasing awareness about the disease. Moreover, an increasing engagement of major market players in the development of growth hormone products is likely to drive market growth.

    June 2021: Novo Nordisk A/S (Denmark) received approval from the US Food and Drug Administration for Wegovy for chronic weight management.

    Figure 2: Human Growth Hormone Market, by Application, 2023 & 2032 (USD Billion)Growth Hormone Market, by Application, 2021 & 2030

    Source: Secondary Research, Primary Research, Market Research Future Database and Analyst Review

    Human Growth Hormone Distribution Channel Insights

    Based on distribution channel, the Human Growth Hormone Market has been segmented into hospital pharmacies, retail pharmacies, online pharmacy, and specialty pharmacy. The hospital pharmacies segment dominated the market in 2021, while online pharmacy is projected to be the fastest-growing segment during the forecast period.

    Moreover, hospital pharmacies are preferred the synthetic or recombinant variants of growth hormone and the ease of availability. In addition, recombinant growth hormone is a prescription medication made available only with a prescription from a physician. Moreover, most hospitals have a policy that patients ought to buy medications prescribed by the practitioners from their premises only.

    Regional Insights

    By Region, the study segments the market into North America, Europe, Asia-Pacific, and Rest of the World. North America Human Growth Hormone market accounted for USD 1.76 billion in 2021 and is expected to exhibit an 10.02% CAGR during the study period. North America accounted for the largest market share due to the surging availability of novel drugs, backed by the existence of a high number of renowned firms and supportive reimbursement policies.

    Moreover, significant government efforts, a well-developed healthcare infrastructure, and a high level of awareness among people is driving the regional market growth during the forecast period.

    Further, the major countries studied are: The US, Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

    Figure 3: GROWTH HORMONE MARKET SHARE BY REGION 2021 (%)GROWTH HORMONE MARKET SHARE BY REGION 2021

    Source: Secondary Research, Primary Research, Market Research Future Database and Analyst Review

    Europe growth hormone market accounts for the second-largest market share due to the increased burden of growth hormone deficiencies, the rising availability of artificial growth hormones, and extensive R&D activities. The burden of growth hormone deficiency is rising in Europe due to stress, improper sleep and low glucose levels among people.

    For instance, in 2018, according to the European Medicines Agency, growth hormone deficiency affected around 4.7 in 10,000 people in the European Union (EU). Furthermore, the Germany Growth Hormone Market held the largest market share, and the France Growth Hormone Market was the fastest growing market in the Europe region.

    The Asia-Pacific Growth Hormone Market is expected to grow at a CAGR of 11.26% from 2024 to 2032. This is due to factors such as penetration of vendors, and a rise in disposable income. Moreover, a surge in drug approvals and the frequent launch of new products also drive market growth.

    Moreover, China Growth Hormone Market held the largest market share, and the India Human Human Growth Hormone Market was the fastest growing market in the Asia-Pacific region.

    Key Players and Competitive Insights

    Major market players are spending a lot of money on R&D to increase their product lines, which will help the growth hormone market grow even more. Market participants are also taking a range of strategic initiatives to grow their worldwide footprint, including new product launches, contractual agreements, mergers and acquisitions, increased investments, and collaboration with other organizations.

    Competitors in the Human Growth Hormone Market industry must offer cost-effective items to expand and survive in an increasingly competitive and rising market environment.

    Novo Nordisk A/S (Denmark) is a Danish pharmaceutical company that discovers, manufactures, and commercializes pharmaceutical products. The company's operating segments are diabetes, hemophilia, growth disorders, obesity, and other biopharmaceuticals. It has a strong clinical pipeline of drugs for type 1 diabetes, type 2 diabetes, obesity, atherosclerosis, hemophilia, and growth disorders.

    For instance, in September 2020, the FDA has approved Novo Nordisk's long-acting human growth hormone, Sogroya (Somapacitan). It's the first of the company's regulatory filings for the medicine, also submitted in the EU and Japan, to win approval.

    Additionally, Pfizer Inc. (US) is a leading research-based biopharmaceutical company applying science and resources to inventive treatments that extend and significantly improve lives. Pfizer discovers, develops, manufactures, and sells healthcare products worldwide. It operates through two segments: Pfizer Innovative Health (IH) and Pfizer Essential Health (EH).

    For instance, in February 2020, Pfizer Inc. and OPKO's (US) Once-Weekly NGENLA (somatrogon) injection received marketing authorization by European Union for the treatment of pediatric growth hormone deficiency.

    Key Companies in the Human Growth Hormone Market market include

    Industry Developments

    January 2022: Ascendis Pharma A/S (Denmark) received the European Commission's approval for TransCon hGH for paediatric growth hormone deficiency. TransCon hGH contains somatropin, which is used for paediatric patients diagnosed with growth hormone deficiency.

    January 2018: Ferring B.V. (Switzerland‎) recieved approval from US Food Drug and Administration for ZOMACTON injection recombinant human growth hormone (GH) indicated for replacement of GH in adults with GH deficiency.

    March 2022: Ipsen Pharma (France) announced the investment in a new state-of-the-art electronic autoinjector for Somatuline Autogel/Somatuline Depot (lanreotide). This product is specifically designed to improve administration and the injection experience for patients.

    Future Outlook

    Human Growth Hormone Market Future Outlook

    The Human Growth Hormone Market is projected to grow at a 9.44% CAGR from 2024 to 2035, driven by rising demand for anti-aging therapies, increased awareness of growth disorders, and advancements in biotechnology.

    New opportunities lie in:

    • Develop personalized HGH therapies targeting specific demographics.
    • Invest in digital health platforms for remote HGH monitoring.
    • Expand distribution channels in emerging markets to increase accessibility.

    By 2035, the Human Growth Hormone Market is poised to achieve substantial growth, reflecting evolving healthcare needs and technological advancements.

    Market Segmentation

    Human Growth Hormone Brand Outlook

    • Norditropin
    • Genotropin
    • Humatrope
    • Saizen
    • Omnitrope
    • Skytrofa
    • Others

    Human Growth Hormone Regional Outlook

    • US
    • Canada
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
    • Middle East
    • Africa
    • Latin America

    Human Growth Hormone Application Outlook

    • Pediatric Growth Hormone Deficiency
    • Adult Growth Hormone Deficiency
    • Idiopathic Growth Hormone Deficiency
    • Small for Gestational Age
    • Turner Syndrome
    • Prader-Willi Syndrome
    • Others

    Human Growth Hormone Distribution Channel Outlook

    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacy
    • Specialty Pharmacy

    Human Growth Hormone Route of Administration Outlook

    • Subcutaneous
    • Intramuscular
    • Intravenous

    Report Scope

    Report Attribute/Metric Details
    Market Size 2023 USD 6.2 billion
    Market Size 2024 USD 6.9 billion
    Market Size 2032 USD 13.5 billion
    Compound Annual Growth Rate (CAGR) 11.3% (2024-2032)
    Base Year 2023
    Forecast Period 2024-2032
    Historical Data 2018 & 2020
    Forecast Units Value (USD Billion)
    Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Segments Covered Brand, Route of Administration, Application, Distribution Channel, and Region
    Geographies Covered North America, Europe, Asia Pacific, and Rest of the World
    Countries Covered The U.S, Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil
    Key Companies Profiled Novo Nordisk A/S (Denmark), Pfizer Inc. (US), Ascendis Pharma A/S (Denmark), EMD Serono (US), Ferring B.V. (Switzerland‎), Zhongshan Sinobioway Hygene Biomedicine Co., Ltd (China), Sandoz International GmbH (Germany), AnkeBio Co., Ltd (China), Ipsen Pharma (France), Genentech (US), and Others
    Key Market Opportunities Increasing number of new product approvals and strategic collaborations among market players
    Key Market Dynamics Increasing awareness about endocrine disorders and effectiveness of growth hormones Rising incidence of growth hormone deficiency

    Market Highlights

    Author
    Kinjoll Dey
    Research Analyst Level I

    He is an extremely curious individual currently working in Healthcare and Medical Devices Domain. Kinjoll is comfortably versed in data centric research backed by healthcare educational background. He leverages extensive data mining and analytics tools such as Primary and Secondary Research, Statistical Analysis, Machine Learning, Data Modelling. His key role also involves Technical Sales Support, Client Interaction and Project management within the Healthcare team. Lastly, he showcases extensive affinity towards learning new skills and remain fascinated in implementing them.

    Get In Touch
    Leave a Comment

    FAQs

    How much is the Human Growth Hormone Market?

    The Human Growth Hormone Market is anticipated to reach 13.5 billion at a CAGR of 11.3% during the forecast period of 2024-2032

    How Big is the U.S Human Growth Hormone Market?

    The US is expected to hold a 35-40% share of the market for Human Growth Hormone Market during the forecast period of 2024-2032.

    What is the growth rate of the Human Growth Hormone Market?

    The human growth hormone market is expected to grow at a 11.3% CAGR during the forecast period from 2024 to 2032.

    Which region held the largest market share in the Human Growth Hormone Market?

    The North America region market held the largest market share.

    Who are the key players in the Human Growth Hormone Market?

    The key players of Human Growth Hormone Market include Novo Nordisk A/S (Denmark), Pfizer Inc. (US), Ascendis Pharma A/S (Denmark), EMD Serono (US), Ferring B.V. (Switzerland‎), Zhongshan Sinobioway Hygene Biomedicine Co., Ltd (China), Pfizer Inc. (US), Sandoz International GmbH (Germany), AnkeBio Co., Ltd (China), Ipsen Pharma (France), and Others.

    Which brand led the Human Growth Hormone Market?

    The Norditropin brand led the human growth hormone market.

    Which application had the largest market share in the Human Growth Hormone Market?

    Pediatric growth hormone deficiency had the largest market share.

    1. Report Prologue
    2. Executive Summary
    3. Market Introduction
      1. Definition 20
      2. Scope of the Study 20
      3. Research Objective 20
      4. Assumptions & Limitations 20
        1. Assumptions 20
        2. Limitations
        3. Market Structure 21
    4. Research Methodology
      1. Research
    5. Process 23
      1. Primary Research 24
      2. Secondary Research 25
    6. Market Size Estimation 26
      1. Forecast Model 26
    7. Market Dynamics
    8. Introduction 28
      1. Drivers 29
        1. Rising cases of growth hormone deficiency
        2. Increasing awareness about the endocrine disorders, and effectiveness
    9. of growth hormones 29
      1. Widener scope of application of growth hormones
      2. Restraints 30
        1. Side-effects associated with the growth hormone
    10. therapy 30
      1. High cost of treatment and lack of health insurance coverage
      2. Opportunities 31
        1. Strong pipeline of hormonal drugs and easy
    11. availability of pharma drugs on E-commerce 31
    12. Market Factor Analysis
    13. Porter’s Five Forces Model 33
      1. Bargaining Power of Suppliers 33
        1. Bargaining Power of Buyers 33
        2. Threat of New Entrants 33
    14. Threat of Substitutes 34
      1. Intensity of Rivalry 34
      2. Supply chain
    15. analysis 34
      1. R&D 34
        1. Manufacturing 34
        2. Distribution
        3. Marketing & Sales 35
        4. Post-Sales Monitoring 35
    16. Investment Opportunities 35
    17. Growth Hormone Market, by Brand
      1. Overview
        1. Norditropin 38
        2. Genotropin 39
        3. Humatrope 39
        4. Saizen 40
        5. Omnitrope 40
        6. Others 40
    18. Growth Hormone
    19. Market, by Application
      1. Overview 42
        1. Growth Hormone Deficiency
        2. Idiopathic Short Stature 44
        3. Small for Gestational Age 44
        4. Turner Syndrome 45
        5. Prader-Willi Syndrome 45
        6. Others
    20. Growth Hormone Market, by Route of Administration
      1. Overview 48
        1. Subcutaneous 49
        2. Intramuscular 50
        3. Intravenous 50
        4. Oral 51
    21. Growth Hormone Market, by Distribution Channel
    22. Overview 53
      1. Hospital Pharmacies 54
        1. Retail Pharmacies 54
        2. Clinics 55
        3. E-Commerce Websites 55
    23. Global Growth Hormone
    24. Market, By Region
      1. Introduction 57
      2. Americas 59
    25. Growth Hormone
    26. Market, by Brand
    27. . Growth Hormone Market, by Application
    28. Growth Hormone
    29. Market, by Route of Administration
    30. Growth Hormone Market, by Distribution Channel
      1. North America 61
    31. Growth Hormone Market, by Brand
    32. . Growth Hormone
    33. Market, by Application
    34. Growth Hormone Market, by Route of Administration
    35. Growth Hormone Market, by Distribution Channel
      1. U.S. 63
    36. Growth
    37. Hormone Market, by Brand
    38. . Growth Hormone Market, by Application
    39. Growth
    40. Hormone Market, by Route of Administration
    41. Growth Hormone Market, by Distribution
    42. Channel
      1. Canada 64
    43. Growth Hormone Market, by Brand
    44. . Growth
    45. Hormone Market, by Application
    46. Growth Hormone Market, by Route of Administration
    47. Growth Hormone Market, by Distribution Channel
      1. South America 66
    48. Growth Hormone Market, by Brand
    49. . Growth Hormone Market, by Application
    50. Growth Hormone Market, by Route of Administration
    51. Growth Hormone Market,
    52. by Distribution Channel
      1. Europe 68
    53. Growth Hormone Market, by Brand
    54. . Growth Hormone Market, by Application
    55. Growth Hormone Market, by Route of
    56. Administration
    57. Growth Hormone Market, by Distribution Channel
      1. Western
    58. Europe 70
    59. Growth Hormone Market, by Brand
    60. . Growth Hormone Market, by
    61. Application
    62. Growth Hormone Market, by Route of Administration
    63. Growth Hormone
    64. Market, by Distribution Channel
      1. Germany 72
    65. Growth Hormone Market,
    66. by Brand
    67. . Growth Hormone Market, by Application
    68. Growth Hormone Market,
    69. by Route of Administration
    70. Growth Hormone Market, by Distribution Channel
      1. France 73
    71. Growth Hormone Market, by Brand
    72. . Growth Hormone
    73. Market, by Application
    74. Growth Hormone Market, by Route of Administration
    75. Growth Hormone Market, by Distribution Channel
      1. U.K 75
    76. Growth
    77. Hormone Market, by Brand
    78. . Growth Hormone Market, by Application
    79. Growth
    80. Hormone Market, by Route of Administration
    81. Growth Hormone Market, by Distribution
    82. Channel
      1. Italy 76
    83. Growth Hormone Market, by Brand
    84. . Growth
    85. Hormone Market, by Application
    86. Growth Hormone Market, by Route of Administration
    87. Growth Hormone Market, by Distribution Channel
      1. Spain 78
    88. Growth
    89. Hormone Market, by Brand
    90. . Growth Hormone Market, by Application
    91. Growth
    92. Hormone Market, by Route of Administration
    93. Growth Hormone Market, by Distribution
    94. Channel
      1. Rest of Western Europe 79
    95. Growth Hormone Market, by Brand
    96. . Growth Hormone Market, by Application
    97. Growth Hormone Market, by Route of
    98. Administration
    99. Growth Hormone Market, by Distribution Channel
      1. Eastern
    100. Europe 81
    101. Growth Hormone Market, by Brand
    102. . Growth Hormone Market, by
    103. Application
    104. Growth Hormone Market, by Route of Administration
    105. Growth Hormone
    106. Market, by Distribution Channel
      1. Asia Pacific 83
    107. Growth Hormone Market,
    108. by Brand
    109. . Growth Hormone Market, by Application
    110. Growth Hormone Market,
    111. by Route of Administration
    112. Growth Hormone Market, by Distribution Channel
      1. Japan 85
    113. Growth Hormone Market, by Brand
    114. . Growth Hormone Market,
    115. by Application
    116. Growth Hormone Market, by Route of Administration
    117. Growth
    118. Hormone Market, by Distribution Channel
      1. China 87
    119. Growth Hormone
    120. Market, by Brand
    121. . Growth Hormone Market, by Application
    122. Growth Hormone
    123. Market, by Route of Administration
    124. Growth Hormone Market, by Distribution Channel
      1. India 88
    125. Growth Hormone Market, by Brand
    126. . Growth Hormone Market,
    127. by Application
    128. Growth Hormone Market, by Route of Administration
    129. Growth
    130. Hormone Market, by Distribution Channel
      1. Australia 90
    131. Growth Hormone
    132. Market, by Brand
    133. . Growth Hormone Market, by Application
    134. Growth Hormone
    135. Market, by Route of Administration
    136. Growth Hormone Market, by Distribution Channel
      1. Republic of Korea 91
    137. Growth Hormone Market, by Brand
    138. . Growth
    139. Hormone Market, by Application
    140. Growth Hormone Market, by Route of Administration
    141. Growth Hormone Market, by Distribution Channel
      1. Rest of Asia Pacific
    142. Growth Hormone Market, by Brand
    143. . Growth Hormone Market, by Application
    144. Growth Hormone Market, by Route of Administration
    145. Growth Hormone Market,
    146. by Distribution Channel
      1. The Middle East & Africa 95
    147. Growth Hormone
    148. Market, by Brand
    149. . Growth Hormone Market, by Application
    150. Growth Hormone
    151. Market, by Route of Administration
    152. Growth Hormone Market, by Distribution Channel
      1. Overview 95
      2. GCC 98
    153. Growth Hormone Market, by Brand
    154. Growth Hormone Market, by Application
    155. Growth Hormone Market, by Route of Administration
    156. Growth Hormone Market, by Distribution Channel
      1. Saudi Arabia 100
    157. Growth Hormone Market, by Brand
    158. . Growth Hormone Market, by Application
    159. Growth Hormone Market, by Route of Administration
    160. Growth Hormone Market,
    161. by Distribution Channel
      1. United Arab Emirates 102
    162. Growth Hormone
    163. Market, by Brand
    164. . Growth Hormone Market, by Application
    165. Growth Hormone
    166. Market, by Route of Administration
    167. Growth Hormone Market, by Distribution Channel
      1. Kuwait 103
    168. Growth Hormone Market, by Brand
    169. . Growth Hormone Market,
    170. by Application
    171. Growth Hormone Market, by Route of Administration
    172. Growth
    173. Hormone Market, by Distribution Channel
      1. Qatar 105
    174. Growth Hormone
    175. Market, by Brand
    176. . Growth Hormone Market, by Application
    177. Growth Hormone
    178. Market, by Route of Administration
    179. Growth Hormone Market, by Distribution Channel
      1. Oman 106
    180. Growth Hormone Market, by Brand
    181. . Growth Hormone Market,
    182. by Application
    183. Growth Hormone Market, by Route of Administration
    184. Growth
    185. Hormone Market, by Distribution Channel
      1. Bahrain 108
    186. Growth Hormone
    187. Market, by Brand
    188. . Growth Hormone Market, by Application
    189. Growth Hormone
    190. Market, by Route of Administration
    191. Growth Hormone Market, by Distribution Channel
      1. Middle East 110
    192. Growth Hormone Market, by Brand
    193. . Growth Hormone
    194. Market, by Application
    195. Growth Hormone Market, by Route of Administration
    196. Growth Hormone Market, by Distribution Channel
      1. Egypt 112
    197. Growth
    198. Hormone Market, by Brand
    199. . Growth Hormone Market, by Application
    200. Growth
    201. Hormone Market, by Route of Administration
    202. Growth Hormone Market, by Distribution
    203. Channel
      1. Jordan 113
    204. Growth Hormone Market, by Brand
    205. . Growth
    206. Hormone Market, by Application
    207. Growth Hormone Market, by Route of Administration
    208. Growth Hormone Market, by Distribution Channel
      1. Lebanon 115
    209. Growth
    210. Hormone Market, by Brand
    211. . Growth Hormone Market, by Application
    212. Growth
    213. Hormone Market, by Route of Administration
    214. Growth Hormone Market, by Distribution
    215. Channel
      1. Iran 116
    216. Growth Hormone Market, by Brand
    217. . Growth
    218. Hormone Market, by Application
    219. Growth Hormone Market, by Route of Administration
    220. Growth Hormone Market, by Distribution Channel
      1. Iraq 118
    221. Growth
    222. Hormone Market, by Brand
    223. . Growth Hormone Market, by Application
    224. Growth
    225. Hormone Market, by Route of Administration
    226. Growth Hormone Market, by Distribution
    227. Channel
      1. Rest of Middle East 119
    228. Growth Hormone Market, by Brand
    229. . Growth Hormone Market, by Application
    230. Growth Hormone Market, by Route of
    231. Administration
    232. Growth Hormone Market, by Distribution Channel
      1. Africa
    233. Growth Hormone Market, by Brand
    234. . Growth Hormone Market, by Application
    235. Growth Hormone Market, by Route of Administration
    236. Growth Hormone Market,
    237. by Distribution Channel
      1. South Africa 123
    238. Growth Hormone Market,
    239. by Brand
    240. . Growth Hormone Market, by Application
    241. Growth Hormone Market,
    242. by Route of Administration
    243. Growth Hormone Market, by Distribution Channel
      1. Morocco 124
    244. Growth Hormone Market, by Brand
    245. . Growth Hormone
    246. Market, by Application
    247. Growth Hormone Market, by Route of Administration
    248. Growth Hormone Market, by Distribution Channel
      1. Algeria 126
    249. Growth
    250. Hormone Market, by Brand
    251. . Growth Hormone Market, by Application
    252. Growth
    253. Hormone Market, by Route of Administration
    254. Growth Hormone Market, by Distribution
    255. Channel
      1. Tunisia 127
    256. Growth Hormone Market, by Brand
    257. . Growth
    258. Hormone Market, by Application
    259. Growth Hormone Market, by Route of Administration
    260. Growth Hormone Market, by Distribution Channel
      1. Rest of Africa 129
    261. Growth Hormone Market, by Brand
    262. . Growth Hormone Market, by Application
    263. Growth Hormone Market, by Route of Administration
    264. Growth Hormone Market,
    265. by Distribution Channel
    266. Competitive Landscape
      1. Company Market Share
    267. Analysis 132
      1. Key Developments 133
    268. Company Profiles
      1. Novo
    269. Nordisk A/S 135
      1. Company Overview 135
        1. Financial Overview
        2. Products Offering 136
        3. Key Developments 136
    270. SWOT Analysis 136
      1. Key Strategy 136
      2. Pfizer Inc. 137
    271. Company Overview 137
      1. Financial Overview 137
        1. Products Offering
        2. Key Developments 138
        3. SWOT Analysis 138
        4. Key
    272. Strategy 138
      1. Novartis AG 139
        1. Company Overview 139
    273. Financial Overview 139
      1. Products Offering 140
        1. Key Developments
        2. SWOT Analysis 140
        3. Key Strategy 140
      2. Anhui Anke
    274. Biotechnology (Group) Co., Ltd 141
      1. Company Overview 141
    275. Financial Overview 141
      1. Products Offering 141
        1. Key Developments
        2. SWOT Analysis 141
        3. Key Strategy 141
      2. Biopartners
    276. GmbH 142
      1. Company Overview 142
        1. Financial Overview 142
        2. Products Offering 143
        3. Key Developments 143
        4. SWOT
    277. Analysis 143
      1. Key Strategy 143
      2. Ipsen S.A. 144
        1. Company
    278. Overview 144
      1. Financial Overview 144
        1. Products Offering 145
        2. Key Developments 145
        3. SWOT Analysis 145
        4. Key Strategy
      2. Eli Lily and Company 146
        1. Company Overview 146
    279. Financial Overview 146
      1. Products Offering 147
        1. Key Developments
        2. SWOT Analysis 147
        3. Key Strategy 147
      2. Merck KGaA
        1. Company Overview 148
        2. Financial Overview 148
    280. Products Offering 149
      1. Key Developments 149
        1. SWOT Analysis
        2. Key Strategy 149
      2. GeneScience Pharmaceuticals Co., Ltd
        1. Company Overview 150
        2. Financial Overview 150
    281. Products Offering 150
      1. Key Developments 150
        1. SWOT Analysis
        2. Key Strategy 151
      2. Lifetech Labs 152
        1. Company
    282. Overview 152
      1. Financial Overview 152
        1. Products Offering
        2. Key Developments 152
        3. SWOT Analysis 152
    283. Key Strategy 153
      1. Genetech Inc. 154
        1. Company Overview 154
        2. Financial Overview 154
        3. Products Offering 155
    284. Key Developments 155
      1. SWOT Analysis 155
        1. Key Strategy 155
      2. Zhongshan Hygene Biopharm Co., Ltd 156
        1. Company Overview 156
        2. Financial Overview 156
        3. Products Offering 156
    285. Key Developments 156
      1. SWOT Analysis 156
        1. Key Strategy 156
    286. Appendix
      1. Discussion Blue Print 158
    287. List of Tables
    288. MARKET SYNOPSIS 18
    289. HORMONE MARKET BY BRAND, 2020-2027 (USD MILLION) 38
    290. MARKET FOR NORDITROPIN, BY REGION, 2020-2027 (USD MILLION) 38
    291. GROWTH HORMONE MARKET FOR GENOTROPIN, BY REGION, 2020-2027 (USD MILLION) 39
    292. GLOBAL GROWTH HORMONE MARKET FOR HUMATROPE, BY REGION, 2020-2027 (USD MILLION)
    293. MILLION) 40
    294. 2027 (USD MILLION) 40
    295. 2027 (USD MILLION) 43
    296. HORMONE DEFICIENCY, BY REGION, 2020-2027 (USD MILLION) 43
    297. HORMONE MARKET FOR IDIOPATHIC SHORT STATURE, BY REGION, 2020-2027 (USD MILLION)
    298. REGION, 2020-2027 (USD MILLION) 44
    299. TURNER SYNDROME, BY REGION, 2020-2027 (USD MILLION) 45
    300. HORMONE MARKET FOR PRADER-WILLI SYNDROME, BY REGION, 2020-2027 (USD MILLION) 45
    301. MILLION) 49
    302. 2027 (USD MILLION) 49
    303. BY REGION, 2020-2027 (USD MILLION) 50
    304. FOR INTRAVENOUS, BY REGION, 2020-2027 (USD MILLION) 50
    305. HORMONE MARKET FOR ORAL, BY REGION, 2020-2027 (USD MILLION) 51
    306. GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION) 53
    307. GLOBAL GROWTH HORMONE MARKET FOR HOSPITAL PHARMACIES, BY REGION, 2020-2027 (USD
    308. MILLION) 54
    309. REGION, 2020-2027 (USD MILLION) 54
    310. CLINICS, BY REGION, 2020-2027 (USD MILLION) 55
    311. MARKET FOR E-COMMERCE WEBSITES, BY REGION, 2020-2027 (USD MILLION) 55
    312. GLOBAL GROWTH HORMONE MARKET, BY REGION, 2020-2027 (USD MILLION) 57
    313. AMERICAS: GROWTH HORMONE MARKET, BY REGION, 2020-2027 (USD MILLION) 59
    314. AMERICAS GROWTH HORMONE MARKET, BY BRAND, 2020-2027 (USD MILLION) 60
    315. AMERICAS GROWTH HORMONE MARKET, BY APPLICATIONS, 2020-2027 (USD MILLION) 60
    316. (USD MILLION) 60
    317. 2027 (USD MILLION) 61
    318. COUNTRY, 2020-2027 (USD MILLION) 61
    319. BY BRAND, 2020-2027 (USD MILLION) 61
    320. MARKET, BY APPLICATIONS, 2020-2027 (USD MILLION) 62
    321. GROWTH HORMONE MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION) 62
    322. (USD MILLION) 62
    323. MILLION) 63
    324. (USD MILLION) 63
    325. 2027 (USD MILLION) 63
    326. CHANNEL, 2020-2027 (USD MILLION) 64
    327. BY BRAND, 2020-2027 (USD MILLION) 64
    328. BY APPLICATIONS, 2020-2027 (USD MILLION) 64
    329. MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION) 65
    330. GROWTH HORMONE MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION) 65
    331. SOUTH AMERICA GROWTH HORMONE MARKET, BY BRAND, 2020-2027 (USD MILLION) 66
    332. MILLION) 66
    333. 2027 (USD MILLION) 66
    334. DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION) 67
    335. MARKET, BY REGION, 2020-2027 (USD MILLION) 68
    336. MARKET, BY BRAND, 2020-2027 (USD MILLION) 69
    337. MARKET, BY APPLICATIONS, 2020-2027 (USD MILLION) 69
    338. HORMONE MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION) 69
    339. EUROPE GROWTH HORMONE MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)
    340. MILLION) 70
    341. (USD MILLION) 70
    342. 2027 (USD MILLION) 71
    343. ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION) 71
    344. GROWTH HORMONE MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION) 71
    345. GERMANY GROWTH HORMONE MARKET, BY BRAND, 2020-2027 (USD MILLION) 72
    346. GERMANY GROWTH HORMONE MARKET, BY APPLICATIONS, 2020-2027 (USD MILLION) 72
    347. (USD MILLION) 72
    348. 2027 (USD MILLION) 73
    349. 2027 (USD MILLION) 73
    350. 2027 (USD MILLION) 73
    351. OF ADMINISTRATION, 2020-2027 (USD MILLION) 74
    352. MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION) 74
    353. HORMONE MARKET, BY BRAND, 2020-2027 (USD MILLION) 75
    354. MARKET, BY APPLICATIONS, 2020-2027 (USD MILLION) 75
    355. MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION) 75
    356. GROWTH HORMONE MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION) 76
    357. ITALY GROWTH HORMONE MARKET, BY BRAND, 2020-2027 (USD MILLION) 76
    358. ITALY GROWTH HORMONE MARKET, BY APPLICATIONS, 2020-2027 (USD MILLION) 76
    359. ITALY GROWTH HORMONE MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)
    360. (USD MILLION) 77
    361. (USD MILLION) 78
    362. (USD MILLION) 78
    363. 2027 (USD MILLION) 78
    364. CHANNEL, 2020-2027 (USD MILLION) 79
    365. HORMONE MARKET, BY BRAND, 2020-2027 (USD MILLION) 79
    366. EUROPE GROWTH HORMONE MARKET, BY APPLICATIONS, 2020-2027 (USD MILLION) 79
    367. REST OF WESTERN EUROPE GROWTH HORMONE MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027
    368. (USD MILLION) 80
    369. DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION) 80
    370. HORMONE MARKET, BY BRAND, 2020-2027 (USD MILLION) 81
    371. GROWTH HORMONE MARKET, BY APPLICATIONS, 2020-2027 (USD MILLION) 81
    372. EASTERN EUROPE GROWTH HORMONE MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD
    373. MILLION) 81
    374. CHANNEL, 2020-2027 (USD MILLION) 82
    375. BY COUNTRY, 2020-2027 (USD MILLION) 83
    376. MARKET, BY BRAND, 2020-2027 (USD MILLION) 84
    377. MARKET, BY APPLICATIONS, 2020-2027 (USD MILLION) 84
    378. HORMONE MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION) 84
    379. ASIA PACIFIC GROWTH HORMONE MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)
    380. (USD MILLION) 86
    381. 2027 (USD MILLION) 86
    382. 2027 (USD MILLION) 87
    383. 2027 (USD MILLION) 87
    384. ADMINISTRATION, 2020-2027 (USD MILLION) 87
    385. BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION) 88
    386. MARKET, BY BRAND, 2020-2027 (USD MILLION) 88
    387. MARKET, BY APPLICATIONS, 2020-2027 (USD MILLION) 88
    388. HORMONE MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION) 89
    389. INDIA GROWTH HORMONE MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)
    390. MILLION) 90
    391. 2027 (USD MILLION) 90
    392. CHANNEL, 2020-2027 (USD MILLION) 91
    393. MARKET, BY BRAND, 2020-2027 (USD MILLION) 91
    394. HORMONE MARKET, BY APPLICATIONS, 2020-2027 (USD MILLION) 91
    395. OF KOREA GROWTH HORMONE MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)
    396. 2027 (USD MILLION) 92
    397. BY BRAND, 2020-2027 (USD MILLION) 93
    398. HORMONE MARKET, BY APPLICATIONS, 2020-2027 (USD MILLION) 93
    399. OF ASIA PACIFIC GROWTH HORMONE MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD
    400. MILLION) 93
    401. CHANNEL, 2020-2027 (USD MILLION) 94
    402. HORMONE MARKET, BY REGION, 2020-2027 (USD MILLION) 96
    403. AND AFRICA: GROWTH HORMONE MARKET, BY BRAND, 2020-2027 (USD MILLION) 96
    404. MIDDLE EAST AND AFRICA: GROWTH HORMONE MARKET, BY APPLICATION, 2020-2027 (USD
    405. MILLION) 96
    406. OF ADMINISTRATION, 2020-2027 (USD MILLION) 97
    407. GROWTH HORMONE MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION) 97
    408. GCC: GROWTH HORMONE MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 98
    409. GCC: GROWTH HORMONE MARKET, BY BRAND, 2020-2027 (USD MILLION) 99
    410. GCC: GROWTH HORMONE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 99
    411. GCC: GROWTH HORMONE MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)
    412. (USD MILLION) 100
    413. 2027 (USD MILLION) 100
    414. BY APPLICATION, 2020-2027 (USD MILLION) 100
    415. HORMONE MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION) 101
    416. SAUDI ARABIA: GROWTH HORMONE MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD
    417. MILLION) 101
    418. 2027 (USD MILLION) 102
    419. MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 102
    420. GROWTH HORMONE MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION) 102
    421. 2027 (USD MILLION) 103
    422. 2027 (USD MILLION) 103
    423. 2027 (USD MILLION) 103
    424. OF ADMINISTRATION, 2020-2027 (USD MILLION) 104
    425. MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION) 104
    426. GROWTH HORMONE MARKET, BY BRAND, 2020-2027 (USD MILLION) 105
    427. GROWTH HORMONE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 105
    428. QATAR: GROWTH HORMONE MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)
    429. (USD MILLION) 106
    430. (USD MILLION) 106
    431. (USD MILLION) 106
    432. 2027 (USD MILLION) 107
    433. CHANNEL, 2020-2027 (USD MILLION) 107
    434. BY BRAND, 2020-2027 (USD MILLION) 108
    435. BY APPLICATION, 2020-2027 (USD MILLION) 108
    436. MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION) 108
    437. GROWTH HORMONE MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION) 109
    438. MIDDLE EAST: GROWTH HORMONE MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 110
    439. (USD MILLION) 111
    440. ADMINISTRATION, 2020-2027 (USD MILLION) 111
    441. MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION) 111
    442. GROWTH HORMONE MARKET, BY BRAND, 2020-2027 (USD MILLION) 112
    443. GROWTH HORMONE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 112
    444. EGYPT: GROWTH HORMONE MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)
    445. (USD MILLION) 113
    446. (USD MILLION) 113
    447. 2027 (USD MILLION) 113
    448. OF ADMINISTRATION, 2020-2027 (USD MILLION) 114
    449. MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION) 114
    450. GROWTH HORMONE MARKET, BY BRAND, 2020-2027 (USD MILLION) 115
    451. GROWTH HORMONE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 115
    452. LEBANON: GROWTH HORMONE MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)
    453. (USD MILLION) 116
    454. (USD MILLION) 116
    455. (USD MILLION) 116
    456. 2027 (USD MILLION) 117
    457. CHANNEL, 2020-2027 (USD MILLION) 117
    458. BY BRAND, 2020-2027 (USD MILLION) 118
    459. BY APPLICATION, 2020-2027 (USD MILLION) 118
    460. MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION) 118
    461. GROWTH HORMONE MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION) 119
    462. REST OF MIDDLE EAST: GROWTH HORMONE MARKET, BY BRAND, 2020-2027 (USD MILLION)
    463. (USD MILLION) 119
    464. ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION) 120
    465. EAST: GROWTH HORMONE MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION) 120
    466. (USD MILLION) 122
    467. CHANNEL, 2020-2027 (USD MILLION) 122
    468. MARKET, BY BRAND, 2020-2027 (USD MILLION) 123
    469. HORMONE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 123
    470. AFRICA: GROWTH HORMONE MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)
    471. 2027 (USD MILLION) 124
    472. 2027 (USD MILLION) 124
    473. 2027 (USD MILLION) 124
    474. OF ADMINISTRATION, 2020-2027 (USD MILLION) 125
    475. MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION) 125
    476. GROWTH HORMONE MARKET, BY BRAND, 2020-2027 (USD MILLION) 126
    477. GROWTH HORMONE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 126
    478. ALGERIA: GROWTH HORMONE MARKET, BY ROUTE OF ADMINISTRATION, 2020-

    Market Segmentation for Growth Hormone Market

    Growth Hormone Brand Outlook (USD Billion, 2018-2030)

    • Norditropin  
    • Genotropin   
    • Humatrope   
    • Saizen   
    • Omnitrope   
    • Skytrofa
    • Others

    Growth Hormone Route of Administration Outlook (USD Billion, 2018-2030)

    • Subcutaneous   
    • Intramuscular   
    • Intravenous

    Growth Hormone Application Outlook (USD Billion, 2018-2030)

    • Pediatric Growth Hormone Deficiency
    • Adult Growth Hormone Deficiency
    • Idiopathic Growth Hormone Deficiency
    • Small for Gestational Age
    • Turner Syndrome
    • Prader-Willi Syndrome
    • Others

    Growth Hormone Distribution Channel Outlook (USD Billion, 2018-2030)

    • Hospital Pharmacies   
    • Retail Pharmacies   
    • Online Pharmacy  
    • Specialty Pharmacy

    Growth Hormone Regional Outlook (USD Billion, 2018-2030)

    • North America Outlook (USD Billion, 2018-2030)

      • North America Growth Hormone by Brand
        • Norditropin  
        • Genotropin   
        • Humatrope   
        • Saizen   
        • Omnitrope   
        • Skytrofa
        • Others
      • North America Growth Hormone by Route of Administration
        • Subcutaneous   
        • Intramuscular   
        • Intravenous
      • North America Growth Hormone by Application
        • Pediatric Growth Hormone Deficiency
        • Adult Growth Hormone Deficiency
        • Idiopathic Growth Hormone Deficiency
        • Small for Gestational Age
        • Turner Syndrome
        • Prader-Willi Syndrome
        • Others
      • North America Growth Hormone by Distribution Channel
        • Hospital Pharmacies   
        • Retail Pharmacies   
        • Online Pharmacy  
        • Specialty Pharmacy

    • US Outlook (USD Billion, 2018-2030)

      • US Growth Hormone by Brand
        • Norditropin  
        • Genotropin   
        • Humatrope   
        • Saizen   
        • Omnitrope   
        • Skytrofa
        • Others
      • US Growth Hormone by Route of Administration
        • Subcutaneous   
        • Intramuscular   
        • Intravenous
      • US Growth Hormone by Application
        • Pediatric Growth Hormone Deficiency
        • Adult Growth Hormone Deficiency
        • Idiopathic Growth Hormone Deficiency
        • Small for Gestational Age
        • Turner Syndrome
        • Prader-Willi Syndrome
        • Others
      • US Growth Hormone by Distribution Channel
        • Hospital Pharmacies   
        • Retail Pharmacies   
        • Online Pharmacy  
        • Specialty Pharmacy

    • Canada Outlook (USD Billion, 2018-2030)

      • Canada Growth Hormone by Brand
        • Norditropin  
        • Genotropin   
        • Humatrope   
        • Saizen   
        • Omnitrope   
        • Skytrofa
        • Others
      • Canada Growth Hormone by Route of Administration
        • Subcutaneous   
        • Intramuscular   
        • Intravenous
      • Canada Growth Hormone by Application
        • Pediatric Growth Hormone Deficiency
        • Adult Growth Hormone Deficiency
        • Idiopathic Growth Hormone Deficiency
        • Small for Gestational Age
        • Turner Syndrome
        • Prader-Willi Syndrome
        • Others
      • Canada Growth Hormone by Distribution Channel
        • Hospital Pharmacies   
        • Retail Pharmacies   
        • Online Pharmacy  
        • Specialty Pharmacy

    • Europe Outlook (USD Billion, 2018-2030)

      • Europe Growth Hormone by Brand
        • Norditropin  
        • Genotropin   
        • Humatrope   
        • Saizen   
        • Omnitrope   
        • Skytrofa
        • Others
      • Europe Growth Hormone by Route of Administration
        • Subcutaneous   
        • Intramuscular   
        • Intravenous
      • Europe Growth Hormone by Application
        • Pediatric Growth Hormone Deficiency
        • Adult Growth Hormone Deficiency
        • Idiopathic Growth Hormone Deficiency
        • Small for Gestational Age
        • Turner Syndrome
        • Prader-Willi Syndrome
        • Others
      • Europe Growth Hormone by Distribution Channel
        • Hospital Pharmacies   
        • Retail Pharmacies   
        • Online Pharmacy  
        • Specialty Pharmacy

    • Germany Outlook (USD Billion, 2018-2030)

      • Germany Growth Hormone by Brand
        • Norditropin  
        • Genotropin   
        • Humatrope   
        • Saizen   
        • Omnitrope   
        • Skytrofa
        • Others
      • Germany Growth Hormone by Route of Administration
        • Subcutaneous   
        • Intramuscular   
        • Intravenous
      • Germany Growth Hormone by Application
        • Pediatric Growth Hormone Deficiency
        • Adult Growth Hormone Deficiency
        • Idiopathic Growth Hormone Deficiency
        • Small for Gestational Age
        • Turner Syndrome
        • Prader-Willi Syndrome
        • Others
      • Germany Growth Hormone by Distribution Channel
        • Hospital Pharmacies   
        • Retail Pharmacies   
        • Online Pharmacy  
        • Specialty Pharmacy

    • France Outlook (USD Billion, 2018-2030)

      • France Growth Hormone by Brand
        • Norditropin  
        • Genotropin   
        • Humatrope   
        • Saizen   
        • Omnitrope   
        • Skytrofa
        • Others
      • France Growth Hormone by Route of Administration
        • Subcutaneous   
        • Intramuscular   
        • Intravenous
      • France Growth Hormone by Application
        • Pediatric Growth Hormone Deficiency
        • Adult Growth Hormone Deficiency
        • Idiopathic Growth Hormone Deficiency
        • Small for Gestational Age
        • Turner Syndrome
        • Prader-Willi Syndrome
        • Others
      • France Growth Hormone by Distribution Channel
        • Hospital Pharmacies   
        • Retail Pharmacies   
        • Online Pharmacy  
        • Specialty Pharmacy

    • UK Outlook (USD Billion, 2018-2030)

      • UK Growth Hormone by Brand
        • Norditropin  
        • Genotropin   
        • Humatrope   
        • Saizen   
        • Omnitrope   
        • Skytrofa
        • Others
      • UK Growth Hormone by Route of Administration
        • Subcutaneous   
        • Intramuscular   
        • Intravenous
      • UK Growth Hormone by Application
        • Pediatric Growth Hormone Deficiency
        • Adult Growth Hormone Deficiency
        • Idiopathic Growth Hormone Deficiency
        • Small for Gestational Age
        • Turner Syndrome
        • Prader-Willi Syndrome
        • Others
      • UK Growth Hormone by Distribution Channel
        • Hospital Pharmacies   
        • Retail Pharmacies   
        • Online Pharmacy  
        • Specialty Pharmacy

    • Italy Outlook (USD Billion, 2018-2030)

      • Italy Growth Hormone by Brand
        • Norditropin  
        • Genotropin   
        • Humatrope   
        • Saizen   
        • Omnitrope   
        • Skytrofa
        • Others
      • Italy Growth Hormone by Route of Administration
        • Subcutaneous   
        • Intramuscular   
        • Intravenous
      • Italy Growth Hormone by Application
        • Pediatric Growth Hormone Deficiency
        • Adult Growth Hormone Deficiency
        • Idiopathic Growth Hormone Deficiency
        • Small for Gestational Age
        • Turner Syndrome
        • Prader-Willi Syndrome
        • Others
      • Italy Growth Hormone by Distribution Channel
        • Hospital Pharmacies   
        • Retail Pharmacies   
        • Online Pharmacy  
        • Specialty Pharmacy

    • Spain Outlook (USD Billion, 2018-2030)

      • Spain Growth Hormone by Brand
        • Norditropin  
        • Genotropin   
        • Humatrope   
        • Saizen   
        • Omnitrope   
        • Skytrofa
        • Others
      • Spain Growth Hormone by Route of Administration
        • Subcutaneous   
        • Intramuscular   
        • Intravenous
      • Spain Growth Hormone by Application
        • Pediatric Growth Hormone Deficiency
        • Adult Growth Hormone Deficiency
        • Idiopathic Growth Hormone Deficiency
        • Small for Gestational Age
        • Turner Syndrome
        • Prader-Willi Syndrome
        • Others
      • Spain Growth Hormone by Distribution Channel
        • Hospital Pharmacies   
        • Retail Pharmacies   
        • Online Pharmacy  
        • Specialty Pharmacy

    • Rest of Europe Outlook (USD Billion, 2018-2030)

      • Rest of Europe Growth Hormone by Brand
        • Norditropin  
        • Genotropin   
        • Humatrope   
        • Saizen   
        • Omnitrope   
        • Skytrofa
        • Others
      • Rest of Europe Growth Hormone by Route of Administration
        • Subcutaneous   
        • Intramuscular   
        • Intravenous
      • Rest of Europe Growth Hormone by Application
        • Pediatric Growth Hormone Deficiency
        • Adult Growth Hormone Deficiency
        • Idiopathic Growth Hormone Deficiency
        • Small for Gestational Age
        • Turner Syndrome
        • Prader-Willi Syndrome
        • Others
      • Rest of Europe Growth Hormone by Distribution Channel
        • Hospital Pharmacies   
        • Retail Pharmacies   
        • Online Pharmacy  
        • Specialty Pharmacy
        •  

    • Asia-Pacific Outlook (USD Billion, 2018-2030)

      • Asia-Pacific Growth Hormone by Brand
        • Norditropin  
        • Genotropin   
        • Humatrope   
        • Saizen   
        • Omnitrope   
        • Skytrofa
        • Others
      • Asia-Pacific Growth Hormone by Route of Administration
        • Subcutaneous   
        • Intramuscular   
        • Intravenous
      • Asia-Pacific Growth Hormone by Application
        • Pediatric Growth Hormone Deficiency
        • Adult Growth Hormone Deficiency
        • Idiopathic Growth Hormone Deficiency
        • Small for Gestational Age
        • Turner Syndrome
        • Prader-Willi Syndrome
        • Others
      • Asia-Pacific Growth Hormone by Distribution Channel
        • Hospital Pharmacies   
        • Retail Pharmacies   
        • Online Pharmacy  
        • Specialty Pharmacy

    • Japan Outlook (USD Billion, 2018-2030)

      • Japan Growth Hormone by Brand
        • Norditropin  
        • Genotropin   
        • Humatrope   
        • Saizen   
        • Omnitrope   
        • Skytrofa
        • Others
      • Japan Growth Hormone by Route of Administration
        • Subcutaneous   
        • Intramuscular   
        • Intravenous
      • Japan Growth Hormone by Application
        • Pediatric Growth Hormone Deficiency
        • Adult Growth Hormone Deficiency
        • Idiopathic Growth Hormone Deficiency
        • Small for Gestational Age
        • Turner Syndrome
        • Prader-Willi Syndrome
        • Others
      • Japan Growth Hormone by Distribution Channel
        • Hospital Pharmacies   
        • Retail Pharmacies   
        • Online Pharmacy  
        • Specialty Pharmacy

    • India Outlook (USD Billion, 2018-2030)

      • India Growth Hormone by Brand
        • Norditropin  
        • Genotropin   
        • Humatrope   
        • Saizen   
        • Omnitrope   
        • Skytrofa
        • Others
      • India Growth Hormone by Route of Administration
        • Subcutaneous   
        • Intramuscular   
        • Intravenous
      • India Growth Hormone by Application
        • Pediatric Growth Hormone Deficiency
        • Adult Growth Hormone Deficiency
        • Idiopathic Growth Hormone Deficiency
        • Small for Gestational Age
        • Turner Syndrome
        • Prader-Willi Syndrome
        • Others
      • India Growth Hormone by Distribution Channel
        • Hospital Pharmacies   
        • Retail Pharmacies   
        • Online Pharmacy  
        • Specialty Pharmacy

    • South Korea Outlook (USD Billion, 2018-2030)

      • South Korea Growth Hormone by Brand
        • Norditropin  
        • Genotropin   
        • Humatrope   
        • Saizen   
        • Omnitrope   
        • Skytrofa
        • Others
      • South Korea Growth Hormone by Route of Administration
        • Subcutaneous   
        • Intramuscular   
        • Intravenous
      • South Korea Growth Hormone by Application
        • Pediatric Growth Hormone Deficiency
        • Adult Growth Hormone Deficiency
        • Idiopathic Growth Hormone Deficiency
        • Small for Gestational Age
        • Turner Syndrome
        • Prader-Willi Syndrome
        • Others
      • South Korea Growth Hormone by Distribution Channel
        • Hospital Pharmacies   
        • Retail Pharmacies   
        • Online Pharmacy  
        • Specialty Pharmacy

    • Australia Outlook (USD Billion, 2018-2030)

      • Australia Growth Hormone by Brand
        • Norditropin  
        • Genotropin   
        • Humatrope   
        • Saizen   
        • Omnitrope   
        • Skytrofa
        • Others
      • Australia Growth Hormone by Route of Administration
        • Subcutaneous   
        • Intramuscular   
        • Intravenous
      • Australia Growth Hormone by Application
        • Pediatric Growth Hormone Deficiency
        • Adult Growth Hormone Deficiency
        • Idiopathic Growth Hormone Deficiency
        • Small for Gestational Age
        • Turner Syndrome
        • Prader-Willi Syndrome
        • Others
      • Australia Growth Hormone by Distribution Channel
        • Hospital Pharmacies   
        • Retail Pharmacies   
        • Online Pharmacy  
        • Specialty Pharmacy

    • Rest of Asia-Pacific Outlook (USD Billion, 2018-2030)

      • Rest of Asia-Pacific Growth Hormone by Brand
        • Norditropin  
        • Genotropin   
        • Humatrope   
        • Saizen   
        • Omnitrope   
        • Skytrofa
        • Others
      • Rest of Asia-Pacific Growth Hormone by Route of Administration
        • Subcutaneous   
        • Intramuscular   
        • Intravenous
      • Rest of Asia-Pacific Growth Hormone by Application
        • Pediatric Growth Hormone Deficiency
        • Adult Growth Hormone Deficiency
        • Idiopathic Growth Hormone Deficiency
        • Small for Gestational Age
        • Turner Syndrome
        • Prader-Willi Syndrome
        • Others
      • Rest of Asia-Pacific Growth Hormone by Distribution Channel
        • Hospital Pharmacies   
        • Retail Pharmacies   
        • Online Pharmacy  
        • Specialty Pharmacy

    • Rest of the World Outlook (USD Billion, 2018-2030)

      • Rest of the World Growth Hormone by Brand
        • Norditropin  
        • Genotropin   
        • Humatrope   
        • Saizen   
        • Omnitrope   
        • Skytrofa
        • Others
      • Rest of the World Growth Hormone by Route of Administration
        • Subcutaneous   
        • Intramuscular   
        • Intravenous
      • Rest of the World Growth Hormone by Application
        • Pediatric Growth Hormone Deficiency
        • Adult Growth Hormone Deficiency
        • Idiopathic Growth Hormone Deficiency
        • Small for Gestational Age
        • Turner Syndrome
        • Prader-Willi Syndrome
        • Others
      • Rest of the World Growth Hormone by Distribution Channel
        • Hospital Pharmacies   
        • Retail Pharmacies   
        • Online Pharmacy  
        • Specialty Pharmacy

    • Middle East Outlook (USD Billion, 2018-2030)

      • Middle East Growth Hormone by Brand
        • Norditropin  
        • Genotropin   
        • Humatrope   
        • Saizen   
        • Omnitrope   
        • Skytrofa
        • Others
      • Middle East Growth Hormone by Route of Administration
        • Subcutaneous   
        • Intramuscular   
        • Intravenous
      • Middle East Growth Hormone by Application
        • Pediatric Growth Hormone Deficiency
        • Adult Growth Hormone Deficiency
        • Idiopathic Growth Hormone Deficiency
        • Small for Gestational Age
        • Turner Syndrome
        • Prader-Willi Syndrome
        • Others
      • Middle East Growth Hormone by Distribution Channel
        • Hospital Pharmacies   
        • Retail Pharmacies   
        • Online Pharmacy  
        • Specialty Pharmacy

    • Africa Outlook (USD Billion, 2018-2030)

      • Africa Growth Hormone by Brand
        • Norditropin  
        • Genotropin   
        • Humatrope   
        • Saizen   
        • Omnitrope   
        • Skytrofa
        • Others
      • Africa Growth Hormone by Route of Administration
        • Subcutaneous   
        • Intramuscular   
        • Intravenous
      • Africa Growth Hormone by Application
        • Pediatric Growth Hormone Deficiency
        • Adult Growth Hormone Deficiency
        • Idiopathic Growth Hormone Deficiency
        • Small for Gestational Age
        • Turner Syndrome
        • Prader-Willi Syndrome
        • Others
      • Africa Growth Hormone by Distribution Channel
        • Hospital Pharmacies   
        • Retail Pharmacies   
        • Online Pharmacy  
        • Specialty Pharmacy

    • Latin America Outlook (USD Billion, 2018-2030)

      • Latin America Growth Hormone by Brand
        • Norditropin  
        • Genotropin   
        • Humatrope   
        • Saizen   
        • Omnitrope   
        • Skytrofa
        • Others
      • Latin America Growth Hormone by Route of Administration
        • Subcutaneous   
        • Intramuscular   
        • Intravenous
      • Latin America Growth Hormone by Application
        • Pediatric Growth Hormone Deficiency
        • Adult Growth Hormone Deficiency
        • Idiopathic Growth Hormone Deficiency
        • Small for Gestational Age
        • Turner Syndrome
        • Prader-Willi Syndrome
        • Others
      • Latin America Growth Hormone by Distribution Channel
        • Hospital Pharmacies   
        • Retail Pharmacies   
        • Online Pharmacy  
        • Specialty Pharmacy
    Human Growth Hormone Market Research Report - Global Forecast till 2032 Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Related Reports

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study

    Chemicals and Materials

    Global Magnesium Sulfate Market – Forecast till 2027